Zydus Cadila gets tentative USFDA approval for Droxidopa Capsules

Zydus Cadila gets tentative USFDA approval for Droxidopa Capsules

212
Approved
Picture: Pixabay

Zydus Cadila gets tentative USFDA approval for Droxidopa Capsules

Zydus Cadila has received tentative approval from the USFDA to market Droxidopa capsules in the strengths of 100 mg, 200 mg, and 300 mg. Droxidopa is used to treat symptoms of low blood pressure when standing, caused by a certain medical condition called neurogenic orthostatic hypotension(nOH).

Medicine
Picture: Pixabay

This medication can lessen symptoms of low blood pressure when standing (orthostatic hypotension), such as dizziness and lightheadedness. The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.

Also read: Zydus Cadila’s ELISA kits has 98% sensitivity: ICMR

The group now has 290 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.